Report Content
Chapter 1 Methodology
1.1 Methodology
1.2 Market definitions
1.2.1 North America
1.2.2 Europe
1.2.3 Asia Pacific
1.2.4 Latin America
1.2.5 Middle East
1.2.6 Africa
1.3 Forecast parameters
1.4 Data validation
1.5 Data sources
1.5.1 Secondary
1.5.1.1 Paid sources
1.5.1.2 Unpaid sources
1.5.2 Primary
Chapter 2 Executive Summary
2.1 HIV diagnostics industry 360° synopsis
2.1.1 Business trends
2.1.2 Test type trends
2.1.3 End-use trends
2.1.4 Regional trends
Chapter 3 HIV Diagnostics Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2017 – 2028 (USD Million)
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Favorable regulatory landscape in U
3.3.1.2 Point of Care (P-o-C) HIV diagnostics development
3.3.1.3 Increasing HIV prevalence in low and middle-income countries
3.3.1.4 Increasing government initiatives for HIV awareness
3.3.2 Industry pitfalls and challenges
3.3.2.1 Low degree of penetration in undeveloped regional markets
3.3.2.2 Growing awareness regarding HIV transmission and testing
3.3.2.3 Reduction of HIV cases in developed countries
3.4 Growth potential analysis
3.4.1 By test type
3.4.2 By end-use
3.5 COVID-19 impact analysis
3.6 Regulatory landscape
3.7 Porter’s analysis
3.8 Competitive landscape, 2021
3.8.1 Competitive matrix analysis, 2021
3.9 PESTEL analysis
Chapter 4 HIV Diagnostics Market, By Test Type
4.1 Key segment trends
4.2 Antibody test
4.2.1 Market size, by region, 2017 - 2028 (USD Million)
4.3 Viral load test
4.3.1 Market size, by region, 2017 - 2028 (USD Million)
4.4 CD4 test
4.4.1 Market size, by region, 2017 - 2028 (USD Million)
Chapter 5 HIV Diagnostics Market, By End-use
5.1 Key segment trends
5.2 Diagnostic laboratories
5.2.1 Market size, by region, 2017 - 2028 (USD Million)
5.3 Hospitals & clinics
5.3.1 Market size, by region, 2017 - 2028 (USD Million)
5.4 Home settings
5.4.1 Market size, by region, 2017 - 2028 (USD Million)
5.5 Others
5.5.1 Market size, by region, 2017 - 2028 (USD Million)
Chapter 6 HIV Diagnostics Market, By Region
6.1 Key regional trends
6.2 North America
6.2.1 Market size, by country 2017 - 2028 (USD Million)
6.2.2 Market size, by test type, 2017 - 2028 (USD Million)
6.2.3 Market size, by end-use, 2017 - 2028 (USD Million)
6.2.4 U.S.
6.2.4.1 Market size, by test type, 2017 - 2028 (USD Million)
6.2.4.2 Market size, by end-use, 2017 - 2028 (USD Million)
6.2.5 Canada
6.2.5.1 Market size, by test type, 2017 - 2028 (USD Million)
6.2.5.2 Market size, by end-use, 2017 - 2028 (USD Million)
6.3 Europe
6.3.1 Market size, by country 2017 - 2028 (USD Million)
6.3.2 Market size, by test type, 2017 - 2028 (USD Million)
6.3.3 Market size, by end-use, 2017 - 2028 (USD Million)
6.3.4 Russia
6.3.4.1 Market size, by test type, 2017 - 2028 (USD Million)
6.3.4.2 Market size, by end-use, 2017 - 2028 (USD Million)
6.3.5 France
6.3.5.1 Market size, by test type, 2017 - 2028 (USD Million)
6.3.5.2 Market size, by end-use, 2017 - 2028 (USD Million)
6.3.6 Spain
6.3.6.1 Market size, by test type, 2017 - 2028 (USD Million)
6.3.6.2 Market size, by end-use, 2017 - 2028 (USD Million)
6.3.7 Italy
6.3.7.1 Market size, by test type, 2017 - 2028 (USD Million)
6.3.7.2 Market size, by end-use, 2017 - 2028 (USD Million)
6.3.8 UK
6.3.8.1 Market size, by test type, 2017 - 2028 (USD Million)
6.3.8.2 Market size, by end-use, 2017 - 2028 (USD Million)
6.3.9 Germany
6.3.9.1 Market size, by test type, 2017 - 2028 (USD Million)
6.3.9.2 Market size, by end-use, 2017 - 2028 (USD Million)
6.4 Asia Pacific
6.4.1 Market size, by country 2017 - 2028 (USD Million)
6.4.2 Market size, by test type, 2017 - 2028 (USD Million)
6.4.3 Market size, by end-use, 2017 - 2028 (USD Million)
6.4.4 India
6.4.4.1 Market size, by test type, 2017 - 2028 (USD Million)
6.4.4.2 Market size, by end-use, 2017 - 2028 (USD Million)
6.4.5 China
6.4.5.1 Market size, by test type, 2017 - 2028 (USD Million)
6.4.5.2 Market size, by end-use, 2017 - 2028 (USD Million)
6.5 Latin America
6.5.1 Market size, by country 2017 - 2028 (USD Million)
6.5.2 Market size, by test type, 2017 - 2028 (USD Million)
6.5.3 Market size, by end-use, 2017 - 2028 (USD Million)
6.5.4 Brazil
6.5.4.1 Market size, by test type, 2017 - 2028 (USD Million)
6.5.4.2 Market size, by end-use, 2017 - 2028 (USD Million)
6.5.5 Mexico
6.5.5.1 Market size, by test type, 2017 - 2028 (USD Million)
6.5.5.2 Market size, by end-use, 2017 - 2028 (USD Million)
6.5.6 Argentina
6.5.6.1 Market size, by test type, 2017 - 2028 (USD Million)
6.5.6.2 Market size, by end-use, 2017 - 2028 (USD Million)
6.6 Middle East
6.6.1 Market size, by country 2017 - 2028 (USD Million)
6.6.2 Market size, by test type, 2017 - 2028 (USD Million)
6.6.3 Market size, by end-use, 2017 - 2028 (USD Million)
6.6.4 Iran
6.6.4.1 Market size, by test type, 2017 - 2028 (USD Million)
6.6.4.2 Market size, by end-use, 2017 - 2028 (USD Million)
6.6.5 Saudi Arabia
6.6.5.1 Market size, by test type, 2017 - 2028 (USD Million)
6.6.5.2 Market size, by end-use, 2017 - 2028 (USD Million)
6.6.6 Yemen
6.6.6.1 Market size, by test type, 2017 - 2028 (USD Million)
6.6.6.2 Market size, by end-use, 2017 - 2028 (USD Million)
6.7 Africa
6.7.1 Market size, by country 2017 - 2028 (USD Million)
6.7.2 Market size, by test type, 2017 - 2028 (USD Million)
6.7.3 Market size, by end-use, 2017 - 2028 (USD Million)
6.7.4 South Africa
6.7.4.1 Market size, by test type, 2017 - 2028 (USD Million)
6.7.4.2 Market size, by end-use, 2017 - 2028 (USD Million)
6.7.5 Mozambique
6.7.5.1 Market size, by test type, 2017 - 2028 (USD Million)
6.7.5.2 Market size, by end-use, 2017 - 2028 (USD Million)
6.7.6 Nigeria
6.7.6.1 Market size, by test type, 2017 - 2028 (USD Million)
6.7.6.2 Market size, by end-use, 2017 - 2028 (USD Million)
6.7.7 United Republic of Tanzania
6.7.7.1 Market size, by test type, 2017 - 2028 (USD Million)
6.7.7.2 Market size, by end-use, 2017 - 2028 (USD Million)
6.7.8 Kenya
6.7.8.1 Market size, by test type, 2017 - 2028 (USD Million)
6.7.8.2 Market size, by end-use, 2017 - 2028 (USD Million)
6.7.9 Uganda
6.7.9.1 Market size, by test type, 2017 - 2028 (USD Million)
6.7.9.2 Market size, by end-use, 2017 - 2028 (USD Million)
Chapter 7 Company Profiles
7.1 Strategy dashboard, 2021
7.2 Abbott
7.2.1 Business overview
7.2.2 Financial data
7.2.3 Product landscape
7.2.4 Strategic outlook
7.2.5 SWOT analysis
7.3 OraSure Technologies.
7.3.1 Business overview
7.3.2 Financial data
7.3.3 Product landscape
7.3.4 Strategic outlook
7.3.5 SWOT analysis
7.4 BD
7.4.1 Business overview
7.4.2 Financial data
7.4.3 Product landscape
7.4.4 Strategic outlook
7.4.5 SWOT analysis
7.5 BIONEER CORPORATION
7.5.1 Business overview
7.5.2 Financial data
7.5.3 Product landscape
7.5.4 Strategic outlook
7.5.5 SWOT analysis
7.6 bioMérieux SA
7.6.1 Business overview
7.6.2 Financial data
7.6.3 Product landscape
7.6.4 Strategic outlook
7.6.5 SWOT analysis
7.7 ChemBio Diagnostics Inc.
7.7.1 Business overview
7.7.2 Financial data
7.7.3 Product landscape
7.7.4 Strategic outlook
7.7.5 SWOT analysis
7.8 Qiagen
7.8.1 Business overview
7.8.2 Financial data
7.8.3 Product landscape
7.8.4 Strategic outlook
7.8.5 SWOT analysis
7.9 Roche Diagnostics
7.9.1 Business overview
7.9.2 Financial data
7.9.3 Product landscape
7.9.4 Strategic outlook
7.9.5 SWOT analysis
7.10 Cepheid
7.10.1 Business overview
7.10.2 Financial data
7.10.3 Product landscape
7.10.4 Strategic outlook
7.10.5 SWOT analysis
7.11 Omega Diagnostics
7.11.1 Business overview
7.11.2 Financial data
7.11.3 Product landscape
7.11.4 Strategic outlook
7.11.5 SWOT analysis
